Questionnaire Survey on Driving among Patients with Age-Related Macular Degeneration in Japan

Código QR

Questionnaire Survey on Driving among Patients with Age-Related Macular Degeneration in Japan

Purpose: This study aimed to assess driving capabilities in patients with exudative age-related macular degeneration (AMD) causing unilateral blindness or paracentral scotoma without vision deterioration. Methods: Of the 275 patients with AMD who responded to a questionnaire regarding car driving at...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Chikako Hara, Miki Sawa, Fumi Gomi, Kohji Nishida
Formato:	article
Lenguaje:	EN
Publicado:	MDPI AG 2021
Materias:	age-related macular degeneration driving questionnaire signal colour elderly persons Medicine R
Acceso en línea:	https://doaj.org/article/b55999b6605449f08e3bb5ecfa4da020
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Acquired Vitelliform Macular Degeneration: Characteristics and Challenges of Managing Subretinal Fluid
por: Joseph Juliano, et al.
Publicado: (2021)

Implantation of the First IMT Macular Lens in Age-Related Macular Degeneration (Literature Review)
por: M. M. Bikbov, et al.
Publicado: (2019)

Management of neovascular age-related macular degeneration: Taiwan expert consensus
por: Ling Yeung, et al.
Publicado: (2021)

Full-thickness macular hole formation following anti-VEGF injections for neovascular age-related macular degeneration
por: Kabanarou SA, et al.
Publicado: (2017)

Microcurrent stimulation in the treatment of dry and wet macular degeneration
por: Chaikin L, et al.
Publicado: (2015)

Photobiomodulation Therapy for Age-Related Macular Degeneration and Diabetic Retinopathy: A Review
por: Muste JC, et al.
Publicado: (2021)

Optimized Prediction Models from Fundus Imaging and Genetics for Late Age-Related Macular Degeneration
por: Arun Govindaiah, et al.
Publicado: (2021)

Dietary Antioxidants in Age-Related Macular Degeneration and Glaucoma
por: Jacek Dziedziak, et al.
Publicado: (2021)

Brolucizumab in Neovascular Age-Related Macular Degeneration – Indian Real-World Experience: The BRAILLE Study
por: Chakraborty D, et al.
Publicado: (2021)

Long-term effectiveness of ranibizumab for age-related macular degeneration and diabetic macular edema
por: Fong AH, et al.
Publicado: (2013)

Circulating monocytes and B-lymphocytes in neovascular age-related macular degeneration
por: Hector SM, et al.
Publicado: (2017)

Changing from bevacizumab to ranibizumab in age-related macular degeneration. Is it safe?
por: Dimitrios A Karagiannis, et al.
Publicado: (2009)

Melatonin level as a risk factor for age-related macular degeneration
por: N. S. Khodzhaev, et al.
Publicado: (2021)

CYTOKINES IN LACRIMAL FLUID AND BLOOD SERUM: EARLY BIOMARKERS OF AGE-RELATED MACULAR DEGENERATION
por: O. S. Slepova, et al.
Publicado: (2015)

Associations of ARMS2 and CFH Gene Polymorphisms with Neovascular Age-Related Macular Degeneration
por: Supanji S, et al.
Publicado: (2021)

Prevalence of and risk factors for age-related macular degeneration in Nepal: the Bhaktapur Retina Study
por: Thapa R, et al.
Publicado: (2017)

Recent developments in age-related macular degeneration: a review
por: Al-Zamil WM, et al.
Publicado: (2017)

Response of eyes with age-related macular degeneration to anti-VEGF drugs and implications for therapy planning
por: Miyamoto N, et al.
Publicado: (2017)

Patient Preferences Associated with Anti-Vascular Endothelial Growth Factor Therapies for Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema
por: Bhagat D, et al.
Publicado: (2020)

The burden of neovascular age-related macular degeneration: a patient’s perspective
por: Spooner KL, et al.
Publicado: (2018)

Brolucizumab: evidence to date in the treatment of neovascular age-related macular degeneration
por: Yannuzzi NA, et al.
Publicado: (2019)

PERIPHERAL BLOOD SUBPOPULATION OF LYMPHOCYTES OF PATIENTS WITH AGE-RELATED MACULAR DEGENERATION
por: N. V. Balatskaya, et al.
Publicado: (2015)

Quantitative Imaging Biomarkers in Age-Related Macular Degeneration and Diabetic Eye Disease: A Step Closer to Precision Medicine
por: Gagan Kalra, et al.
Publicado: (2021)

Age-Related Macular Degeneration in Primary Osteoarthritis Egyptian Patients
por: Mahgoub MY, et al.
Publicado: (2020)

To Peel or Not to Peel: Pars Plana Vitrectomy with Macular Membrane Peel in Eyes with Abnormalities of Vitreomacular Interface and Coexisting Dry Age-Related Macular Degeneration
por: Furashova O, et al.
Publicado: (2020)

Macular morphology and response to ranibizumab treatment in patients with wet age-related macular degeneration
por: Dervenis N, et al.
Publicado: (2016)

Identification of lncRNAs involved in biological regulation in early age-related macular degeneration
por: Zhu W, et al.
Publicado: (2017)

Effects of Intravitreous Aflibercept Injection in Pachychoroid Neovasculopathy: Comparison with Typical Neovascular Age-Related Macular Degeneration
por: Elfandi S, et al.
Publicado: (2021)

Switching to aflibercept among patients with treatment-resistant neovascular age-related macular degeneration: a systematic review with meta-analysis
por: Spooner K, et al.
Publicado: (2017)

Agreement of swept-source and spectral-domain optical coherence-tomography retinal thickness measurements in neovascular age-related macular degeneration
por: Hanumunthadu D, et al.
Publicado: (2017)

Combination verteporfin photodynamic therapy ranibizumab-dexamethasone in choroidal neovascularization due to age-related macular degeneration: results of a phase II randomized trial
por: Gallemore RP, et al.
Publicado: (2017)

Plasma Metabolomics of Intermediate and Neovascular Age-Related Macular Degeneration Patients
por: Sabrina L. Mitchell, et al.
Publicado: (2021)

Exploring Consensus on Preventive Measures and Identification of Patients at Risk of Age-Related Macular Degeneration Using the Delphi Process
por: Alfredo García-Layana, et al.
Publicado: (2021)

Location of submacular hemorrhage as a predictor of visual outcome after intravitreal ranibizumab for age-related macular degeneration
por: Karagiannis D, et al.
Publicado: (2017)

Intravitreal use of bone marrow mononuclear fraction containing CD34+ stem cells in patients with atrophic age-related macular degeneration
por: Cotrim CC, et al.
Publicado: (2017)

Cost-Effectiveness of Conbercept vs. Ranibizumab for Age-Related Macular Degeneration, Diabetic Macular Edema, and Pathological Myopia: Population-Based Cohort Study and Markov Model
por: Zhuang Cui, et al.
Publicado: (2021)

Stem cell therapies for age-related macular degeneration: the past, present, and future
por: Dang Y, et al.
Publicado: (2015)

Evaluation of peripheral fundus autofluorescence in eyes with wet age-related macular degeneration
por: Suetsugu T, et al.
Publicado: (2016)

Anxiety and depression in patients with advanced macular degeneration: current perspectives
por: Cimarolli VR, et al.
Publicado: (2015)

Specific Autoantibodies in Neovascular Age-Related Macular Degeneration: Evaluation of Morphological and Functional Progression over Five Years
por: Michelle Prasuhn, et al.
Publicado: (2021)